Ann Arbor, MI, United States of America

Ellen M Berman


Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 1986-1989

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ellen M Berman

Introduction

Ellen M Berman is a notable inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer agents. With a total of 3 patents to her name, her work has had a meaningful impact on medical research and treatment options.

Latest Patents

One of her latest patents involves substituted quinazolinones as anticancer agents. This patent describes novel 6-substituted-4(3H)-quinazolinones and methods for their preparation and pharmaceutical composition. These compounds inhibit the enzyme thymidylate synthase (TS), making them useful as anticancer agents. Another significant patent focuses on substituted benzonitriles, detailing an improved process for preparing 6-substituted-5-alkyl-2,4-quinazolinediamines. These compounds are valuable in the production of trimetrexate and similar antifolate agents, along with several novel intermediates.

Career Highlights

Ellen M Berman has worked with Warner-Lambert Company, where she has been able to apply her innovative ideas in a collaborative environment. Her work has contributed to advancements in pharmaceutical chemistry and drug development.

Collaborations

Throughout her career, Ellen has collaborated with notable colleagues, including Leslie M Werbel and Dennis Joseph McNamara. These partnerships have fostered a productive exchange of ideas and have led to significant advancements in their respective fields.

Conclusion

Ellen M Berman's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to influence the development of effective cancer treatments and showcases the importance of innovation in medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…